Cerner Co. (NASDAQ:CERN) President Zane M. Burke sold 283,539 shares of the company’s stock in a transaction dated Tuesday, September 11th. The shares were sold at an average price of $63.68, for a total transaction of $18,055,763.52. Following the sale, the president now directly owns 59,539 shares of the company’s stock, valued at approximately $3,791,443.52. The sale was disclosed in a filing with the SEC, which is available at this link.
NASDAQ:CERN opened at $64.94 on Friday. The company has a current ratio of 2.85, a quick ratio of 2.83 and a debt-to-equity ratio of 0.09. Cerner Co. has a 1-year low of $52.05 and a 1-year high of $73.86. The stock has a market capitalization of $21.31 billion, a price-to-earnings ratio of 29.52, a PEG ratio of 2.05 and a beta of 0.97.
Cerner (NASDAQ:CERN) last issued its quarterly earnings data on Thursday, August 2nd. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.60 by $0.02. Cerner had a net margin of 16.06% and a return on equity of 15.26%. The firm had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period in the prior year, the business posted $0.61 EPS. The business’s revenue for the quarter was up 5.9% compared to the same quarter last year. equities analysts expect that Cerner Co. will post 2.28 EPS for the current fiscal year.
Several hedge funds have recently modified their holdings of CERN. Alps Advisors Inc. lifted its holdings in shares of Cerner by 15.0% in the 1st quarter. Alps Advisors Inc. now owns 7,624 shares of the company’s stock worth $442,000 after acquiring an additional 996 shares during the last quarter. SG Americas Securities LLC lifted its holdings in shares of Cerner by 18.5% in the 1st quarter. SG Americas Securities LLC now owns 20,871 shares of the company’s stock worth $1,211,000 after acquiring an additional 3,255 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Cerner by 42.3% in the 1st quarter. Victory Capital Management Inc. now owns 47,833 shares of the company’s stock worth $2,774,000 after acquiring an additional 14,208 shares during the last quarter. D.A. Davidson & CO. lifted its holdings in shares of Cerner by 21.2% in the 1st quarter. D.A. Davidson & CO. now owns 5,610 shares of the company’s stock worth $325,000 after acquiring an additional 981 shares during the last quarter. Finally, Quantitative Systematic Strategies LLC acquired a new position in shares of Cerner in the 1st quarter worth approximately $464,000. Hedge funds and other institutional investors own 76.08% of the company’s stock.
Several equities analysts have weighed in on CERN shares. Zacks Investment Research upgraded shares of Cerner from a “sell” rating to a “hold” rating in a report on Tuesday, July 3rd. BidaskClub lowered shares of Cerner from a “hold” rating to a “sell” rating in a report on Friday, May 25th. Cantor Fitzgerald reiterated a “buy” rating and issued a $80.00 target price on shares of Cerner in a report on Wednesday. KeyCorp boosted their target price on shares of Cerner from $71.00 to $74.00 and gave the company an “overweight” rating in a report on Friday, August 3rd. Finally, Royal Bank of Canada boosted their target price on shares of Cerner from $67.00 to $71.00 and gave the company a “buy” rating in a report on Thursday, May 24th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $71.71.
Cerner Company Profile
Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Featured Article: Fundamental Analysis and Individual Investors
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.